Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Static and dynamic network properties of the repetitive transcranial magnetic stimulation target predict changes in emotion regulation in obsessive-compulsive disorder.

Douw L, Quaak M, Fitzsimmons SMDD, de Wit SJ, van der Werf YD, van den Heuvel OA, Vriend C.

Brain Stimul. 2019 Oct 24. pii: S1935-861X(19)30426-7. doi: 10.1016/j.brs.2019.10.017. [Epub ahead of print]

2.

CD14/Toll-like receptors interact with bacteria and regulatory T-cells in the development of childhood asthma.

Klaassen EM, van de Kant KD, Soeteman M, Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van Schayck OC, Jöbsis Q, Dompeling E.

Eur Respir J. 2014 Sep;44(3):799-802. doi: 10.1183/09031936.00020314. Epub 2014 Jul 17. No abstract available.

3.

Pharmacogenetics of smoking: how far to the clinic?

Quaak M, van Schooten FJ, van Schayck CP.

Pharmacogenomics. 2014 Apr;15(6):723-6. doi: 10.2217/pgs.14.34. No abstract available.

PMID:
24897278
4.

Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma.

Klaassen EM, van de Kant KD, Jöbsis Q, Penders J, van Schooten FJ, Quaak M, den Hartog GJ, Koppelman GH, van Schayck CP, van Eys G, Dompeling E.

Pediatr Allergy Immunol. 2014 Mar;25(2):166-72. doi: 10.1111/pai.12187. Epub 2014 Jan 6.

PMID:
24393359
5.

[Pharmacogenetics in the treatment of tobacco addiction].

Quaak M, van Schooten FJ, van Schayck CP.

Tijdschr Psychiatr. 2013;55(11):891-8. Review. Dutch.

6.

Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers.

Quaak M, Smerecnik C, van Schooten FJ, de Vries H, van Schayck CP.

BMJ Open. 2012 Jan 5;2:e000321. doi: 10.1136/bmjopen-2011-000321. Print 2012.

7.

Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis.

Smerecnik C, Grispen JE, Quaak M.

Tob Control. 2012 May;21(3):347-54. doi: 10.1136/tc.2011.042739. Epub 2011 Sep 26. Review.

PMID:
21948804
8.

Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach.

Smerecnik C, Quaak M, van Schayck CP, van Schooten FJ, de Vries H.

Psychol Health. 2011 Aug;26(8):1099-112. doi: 10.1080/08870446.2010.541909. Epub 2011 Jun 28.

PMID:
21678175
9.

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ.

Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21.

PMID:
21658141
10.

Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ.

Eur Respir J. 2009 Mar;33(3):468-80. doi: 10.1183/09031936.00056908. Review.

11.

Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ.

Mutat Res. 2009 Jul 10;667(1-2):44-57. doi: 10.1016/j.mrfmmm.2008.10.015. Epub 2008 Nov 5. Review.

PMID:
19028511
12.

Twelve tips for computer-based assessment in medical education.

Hols-Elders W, Bloemendaal P, Bos N, Quaak M, Sijstermans R, De Jong P.

Med Teach. 2008;30(7):673-8. doi: 10.1080/01421590802279595.

PMID:
18777426

Supplemental Content

Loading ...
Support Center